Manufacturing Tanabe pens deal to sell plants to Towa in post-buyout pivot BioSpaceAfter being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products.Read full story pharminent July 8, 2026 (Last updated: July 9, 2026) BioSpace After being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products. Read full story Post navigation Previous: AstraZeneca, GSK intensify China ties with Sino Biopharm dealsNext: Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK Related Stories Manufacturing BMS banks on Texas for $2.3bn multi-modal manufacturing facility pharminent August 11, 2026 Manufacturing AsymBio to secure $184m to support growth in biologics manufacturing pharminent August 5, 2026 Manufacturing Lilly and Resilience invest $750M in diabetes and obesity drug device supply pharminent July 31, 2026
